UTHealth project aims to improve clinical trials for underserved people with neurological conditions

In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage community partners to improve the design of clinical trials.

Evonik lays off 2,000 staffers; EurekaBio gets $40M for viral vector production; Sarepta unfazed by Novo-Catalent deal

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential updates on new builds, collaborations, recalls and more. Evonik has cut 2,000 staff members

March 8, 2024

AI shows promise for predicting embryonic health without invasive testing

Researchers evaluate the effectiveness of artificial intelligence algorithms in non-invasively predicting embryonic ploidy from embryonic images.

October 30, 2024

After steering Lundbeck through buyouts, layoffs and big approval, Deborah Dunsire will step down

Seasoned biotech CEO Deborah Dunsire is retiring from Lundbeck after five years, making room for Charl van Zyl to step in as president and CEO

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.